SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
Holding SABS?
Track your performance easily

SAB Biotherapeutics (SABS) Ownership - Who Owns SAB Biotherapeutics?

73 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 08, 2023
Eddie Joe Sullivan
President,director
xxxxxxxxxxxxx
$1531
Nov 30, 2023
Samuel Reich
Ceo & Executive Chairman,director
xxxxxxxxxxxxx
$9790
Nov 30, 2023
xxxxxxxxxxxxx
$4500

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,374,081Institution25.72%6,576,204
275,203Institution2.98%762,312
275,203Institution2.98%762,312
84,000Institution0.91%232,680
60,007Institution0.65%166,219
14,469Institution0.16%40,079
7,256Institution0.08%20,099
1,624Institution0.02%4,498
1,073Institution0.01%2,972

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
275,203Institution2.98%762,312
84,000Institution0.91%232,680
60,007Institution0.65%166,219
7,256Institution0.08%20,099
1,624Institution0.02%4,498
1,073Institution0.01%2,972

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
232,567Institution2.52%674,444
42,636Institution0.46%123,644
14,469Institution0.16%40,079

FAQ

Who Owns SAB Biotherapeutics (SABS)?
Currently, no data Available
What percentage of SAB Biotherapeutics (SABS) stock is held by institutional investors?
Currently, no data Available
What percentage of SAB Biotherapeutics (SABS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of SAB Biotherapeutics (SABS)?
Peter Kolchinsky owns the most shares of SAB Biotherapeutics (SABS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis